top of page

About the EXPRESS study

The EXPRESS study is a 3-year NIHR HS&DR funded project. With collaborative effort from colleagues around the UK and input from a PPI Advisory Group, our research will use a variety of methods to evaluate the new prenatal exome sequencing (pES) service. 

You can view our key objectives here.

What is the prenatal exome sequencing service?


Why do we need to evaluate it?


How are we going to evaluate it?

bottom of page